Smart Nanoparticles Target Treatment-Resistant Leukemia
Cleveland News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Researchers at Case Western Reserve University and MetroHealth System have developed smart nanoparticles to combat treatment-resistant leukemia. These RNA-based carriers target specific cancer cells, delivering targeted therapy and slowing growth in lab tests. The method focuses on leukemia stem cells, which drive relapses and depend on a gene called FTO. The nanoparticles, guided by a unique surface marker, precisely silence this gene. Funded by the National Cancer Institute, the research team plans to test these nanoparticles in mouse models, offering new hope for relapsed leukemia patients.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/a22d0656453c86b9